{"nct_id":"NCT02115386","title":"Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib","status":"TERMINATED","status_verified_date":"2019-12","start_date":"2015-12-17","start_date_type":"ACTUAL","primary_completion_date":"2016-10-31","primary_completion_date_type":"ACTUAL","completion_date":"2016-10-31","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}